Serum C-reactive protein and circulating endothelial cells in patients with acute myocardial infarction

Clinical Hemorheology and Microcirculation

Volumn 32, Issue 4, 2005, Pages 287-296

  Wang, Chunling ^a   Li, Hongwei ^a   Fu, Panfeng ^a   Zhang, Shuyang ^a   Xiu, Ruijuan ^a,b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b Chinese Academy of Medical Sciences   (China)

Author keywords

Acute myocardial infarction; C reactive protein; Circulating endothelial cell

Indexed keywords

ANTIBODY; C REACTIVE PROTEIN; CD31 ANTIGEN; CHOLESTEROL; VON WILLEBRAND FACTOR;

ACUTE HEART INFARCTION; ADULT; AGED; APOPTOSIS; ARTICLE; BLOOD; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; GENDER; HUMAN; HYPERTENSION; INFECTION; INFLAMMATION; MALE; NECROSIS; NORMAL HUMAN; OBESITY; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SMOKING; VASCULAR DISEASE;

ANTIGENS, CD; ANTIGENS, CD146; ANTIGENS, CD31; APOPTOSIS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CELLS, CULTURED; CHOLESTEROL; COHORT STUDIES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOMAGNETIC SEPARATION; INFLAMMATION; MICROSCOPY, ELECTRON; MYOCARDIAL INFARCTION; NEURAL CELL ADHESION MOLECULES; OBESITY; VON WILLEBRAND FACTOR;

EID: 19344377841     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. A. Woywodt, F. Streiber, K. de Groot, H. Regelsberger, H. Haller and M. Haubitz, Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis, Lancet 361 (2003), 206-210.
2. J.D. Belcher, C.J. Bryant, J. Nguyen, P.R. Bowlin, M.C. Kielbik, J.C. Bischof, R.P. Hebbel and G.M. Vercellotti, Transgenic sickle mice have vascular inflammation, Blood 101 (2003), 3953-3959.
3. T.M. Bull, H. Golpon, R.P. Hebbel, A. Solovey, C.D. Cool, R.M. Tuder, M.W. Geraci and N.F. Voelkel, Circulating endothelial cells in pulmonary hypertension, Thromb. Haemost. 90 (2003), 698-703.
4. F. Dignat-George and J. Sampol, Circulating endothelial cells in vascular disorders: new insights into an old concept, Eur. J. Haematol. 65 (2000), 215-220.
5. J.T. Willerson, Systemic and local inflammation in patients with unstable atherosclerotic plaques, Prog. Cardiovasc. Dis. 44 (2002), 469-478.
6. R.J. Xiu, A. Freyschuss, X. Ying, L. Berglund, P. Henriksson and I. Bjorkhem, The antioxidant butylated hydroxytoluene prevents early cholesterol-induced microcirculatory changes in rabbits, J. Clin. Invest. 93 (1994), 2732-2737.
7. R. Ross, The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature 362 (1993), 801-809.
8. P. Libby, P.M. Ridker and A. Maseri, Inflammation and atherosclerosis, Circulation 105 (2002), 1135-1143.
9. G. Engstrom, P. Lind, B. Hedblad, L. Stavenow, L. Janzon and F. Lindgarde, Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men, Circulation 105 (2002), 2632-2637.
10. M.B. Pepys, C-reactive protein fifty years on, Lancet 1 (1981), 653-657.
11. G. Liuzzo, L.M. Biasucci, J.R. Gallimore, R.L. Grillo, A.G. Rebuzzi, M.B. Pepys and A. Maseri, The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina, N. Engl. J. Med. 331 (1994), 417-424.
12. M. Mutin, I. Canavy, A. Blann, M. Bory, J. Sampol and F. Dignat-George, Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells, Blood 93 (1999), 2951-2958.
13. http://www.acc.org/clinical/guidelines/nov96/1999/amipdf99.pdf.
14. E.A. Jaffe, R.L. Nachman, C.G. Becker and C.R. Minick, Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria, J. Clin. Invest. 52 (1973), 2745-2756.
15. A. Hijazi, M. Devonec, R. Bouvier, G. Escourrou, A. Longin, P. Perrin and J.P. Revillard, Phenotyping of 76 human bladder tumors with a panel of monoclonal antibodies: correlation between pathology, surface immunofluorescence and DNA content, Eur. J. Cancer Clin. Oncol. 25 (1989), 777-783.
16. A. Solovey, Y. Lin, P. Browne, S. Choong, E. Wayner and R.P. Hebbel, Circulating activated endothelial cells in sickle cell anemia, N. Engl. J. Med. 337 (1997), 1584-1590.
17. M. Koc, A. Bihorac and M.S. Segal, Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients, Am. J. Kidney Dis. 42 (2003), 704-712.
18. F. George, P. Poncelet, J.C. Laurent, O. Massot, D. Arnoux, N. Lequeux, P. Ambrosi, C. Chicheportiche and J. Sampol, Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody, J. Immunol. Methods 139 (1991), 65-75.
19. J.W. Davis, L. Shelton, D.A. Eigenberg, C.E. Hignite and I.S. Watanabe, Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets, Clin. Pharmacol. Ther. 37 (1985), 529-533.
20. X. Chi, H.W. Li, L.S. Xiao and R.J. Xiu, Changes in the level of circulating endothelial cells in acute myocardial infarction patients and the detection of its apoptosis, J. Chine. Microcirc. 3 (1999), 102-105.
21. J. Hladovec, I. Prerovsky, V. Stanek and J. Fabian, Circulating endothelial cells in acute myocardial infarction and angina pectoris, Klin. Wochenschr. 56 (1978), 1033-1036.
22. P. Butthep, I. Nuchprayoon and N. Futrakul, Endothelial injury and altered hemodynamics in thalassemia, Clin. Hemorheol. Microcirc. 31 (2004), 287-293.
23. P. Libby, Y.J. Geng, M. Aikawa, U. Schoenbeck, F. Mach, S.K. Clinton, G.K. Sukhova and R.T. Lee, Macrophages and atherosclerotic plaque stability, Curr. Opin. Lipidol. 7 (1996), 330-335.
24. V. Pasceri, J.T. Willerson and E.T. Yeh, Direct proinflammatory effect of C-reactive protein on human endothelial cells, Circulation 102 (2000), 2165-2168.
25. D. Gertz, M.L. Rennels and E. Nelson, Endothelial cell ischemic injury: protective effect of heparin or aspirin assessed by scanning electron microscopy, Stroke 6 (1975), 357-360.
26. J. Hladovec, The effect of heparin on endothelial stability, Thromb. Res. 35 (1984), 347-352.
27. G. Montalescot, C. Bal-dit-Sollier, D. Chibedi, J.P. Collet, T. Soulat, M. Dalby, R. Choussat, A. Cohen, M. Slama, P.G. Steg, J.L. Dubois-Rande, J.P. Metzger, F. Tarragano, J.L. Guermonprez and L. Drouet, ARMADA Investigators, Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study), Am. J. Cardiol. 91 (2003), 925-930.
28. J. Hladovec, Circulating endothelial cells as a sign of vessel wall lesions, Physiol. Bohemoslov. 27 (1978), 140-144.
29. T. Anzai, T. Yoshikawa, T. Takahashi, Y. Maekawa, T. Okabe, Y. Asakura, T. Satoh, H. Mitamura and S. Ogawa, Early use of beta-blockers is associated with attenuation of serum C-reactive protein elevation and favorable short-term prognosis after acute myocardial infarction, Cardiology 99 (2003), 47-53.
30. S. Solheim, H. Arnesen, L. Eikvar, M. Hurlen and I. Seljeflot, Influence of aspirin on inflammatory markers in patients after acute myocardial infarction, Am. J. Cardiol. 92 (2003), 843-845.